NCT03112668 - Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 6, 2017

Primary Completion Date

January 25, 2018

Study Completion Date

January 25, 2018

Conditions

Malignant Female Reproductive System NeoplasmMalignant Hepatobiliary NeoplasmPartnerStage III Breast CancerStage III Cervical CancerStage III Colorectal CancerStage III Lung CancerStage III Prostate CancerStage III Skin MelanomaStage III Uterine Corpus CancerStage IIIA Breast CancerStage IIIA Cervical CancerStage IIIA Colorectal CancerStage IIIA Lung CarcinomaStage IIIA Skin MelanomaStage IIIA Uterine Corpus CancerStage IIIB Breast CancerStage IIIB Cervical CancerStage IIIB Colorectal CancerStage IIIB Lung CarcinomaStage IIIB Skin MelanomaStage IIIB Uterine Corpus CancerStage IIIC Breast CancerStage IIIC Colorectal CancerStage IIIC Skin MelanomaStage IIIC Uterine Corpus CancerStage IV Breast CancerStage IV Cervical CancerStage IV Colorectal CancerStage IV Lung CancerStage IV Prostate CancerStage IV Skin MelanomaStage IV Uterine Corpus CancerStage IVA Cervical CancerStage IVA Colorectal CancerStage IVA Uterine Corpus CancerStage IVB Cervical CancerStage IVB Colorectal CancerStage IVB Uterine Corpus Cancer

Interventions

BEHAVIORAL

Cognitive Behavior Therapy

Undergo ACT

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Survey Administration

Ancillary studies

Trial Locations (1)

08903

Rutgers Cancer Institute of New Jersey, New Brunswick

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Rutgers, The State University of New Jersey

OTHER